Distal pancreatectomy with celiac axis resection for pancreatic body and tail cancer invading celiac axis.

Distal pancreatectomy with celiac axis resection for pancreatic body and tail cancer invading celiac axis. Ann Surg Treat Res. 2015 Oct;89(4):167-75 Authors: Ham H, Kim SG, Kwon HJ, Ha H, Choi YY Abstract PURPOSE: Pancreatic body/tail cancer often involves the celiac axis (CA) and it is regarded as an unresectable disease. To treat the disease, we employed distal pancreatectomy with en bloc celiac axis resection (DP-CAR) and reviewed our experiences. METHODS: We performed DP-CAR for seven patients with pancreatic body/tail cancer involving the CA. The indications of DP-CAR initially included tumors with definite invasion of CA and were later expanded to include borderline resectable disease. To determine the efficacy of DP-CAR, the clinico-pathological data of patients who underwent DP-CAR were compared to both distal pancreatectomy (DP) group and no resection (NR) group. RESULTS: The R0 resection rate was 71.4% and was not statistically different compared to DP group. The operative time (P = 0.018) and length of hospital stay (P = 0.022) were significantly longer in DP-CAR group but no significant difference was found in incidence of the postoperative pancreatic fistula compared to DP group. In DP-CAR group, focal hepatic infarction and transient hepatopathy occurred in 1 patient and 3 patients, respectively. No mortality occurred in DP-CAR group. The median survival time (MST) was not statistically different compared to DP group. However, the MS...
Source: Annals of Surgical Treatment and Research - Category: Surgery Tags: Ann Surg Treat Res Source Type: research

Related Links:

The cancer organization today largely reinstated its former advice that men with low-risk prostate cancer be offered active surveillance as the lone'preferred'initial treatment option.News Alerts
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
Cancer Gene Therapy, Published online: 01 December 2021; doi:10.1038/s41417-021-00402-9Correction: microRNA-let-7e in serum-derived exosomes inhibits the metastasis of non-small-cell lung cancer in a SUV39H2/LSD1/CDH1-dependent manner
Source: Cancer Gene Therapy - Category: Cancer & Oncology Authors: Source Type: research
Late-phase clinical trials that are currently recruiting patients with noncolorectal gastrointestinal (GI) cancers could be of benefit to your patients.Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news
Child and adolescent survivors of cancer —particularly those experiencing cognitive problems—may be at higher risk of suicidal thoughts than other youth their age, suggests areport inPsycho-Oncology.“Survivors of pediatric cancer are at elevated risk for both neurocognitive and psychological difficulties following cancer treatment,” wrote Christina M. Sharkey, Ph.D., of Children’s National Hospital in Washington, D.C., and colleagues. Studies of adult cancer survivors suggest there may be a link between neurocognitive deficits and suicidal ideation, but little is known of whether such deficits...
Source: Psychiatr News - Category: Psychiatry Tags: adolescents behavioral regulation children cognitive problems inattention IQ parents pediatric cancer processing speed psycho-oncology suicidal ideation teachers working memory Source Type: research
This study sought to design and validate a  nomogram capable of predicting outcomes in extensive-stage small-cell lung cancer (ES-SCLC) patients with superior vena cava syndrome (SVCS) based upon the timing of their radiotherapy treatment.MethodsWe retrospectively analyzed data from 175 ES-SCLC patients with SCVS, comparing outcomes between those that underwent upfront thoracic radiotherapy (initial radiotherapy with simultaneous chemotherapy) and those that underwent consolidative thoracic radiotherapy (following 4 –6 cycles of chemotherapy). Significant predictors of patient outcomes were identified using...
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
ConclusionMagnetic Resonance Image (MRI) linac-based planning for HNC is already feasible with good quality. Generally, an increased number of segments and increasing planning experience are able to provide better results regarding planning quality without significantly prolonging overall treatment time.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
AbstractA  70-year old male with stage I large cell neuroendocrine carcinoma (LCNEC) of the lung underwent resection of a metachronous 5 cm brain metastasis and received postoperative hypofractionated stereotactic radiotherapy (hfSRT). Five sequential nodular leptomeningeal metastases up to 5.3 cm in di ameter were diagnosed on MRI within 10 months and were treated with SRT. Currently the patient has no evidence of intracranial disease 24 months after last irradiation without chemotherapy or whole brain radiotherapy. This is the first report of sustained complete remission of multiple large lepto me...
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
The objective of this study was to assess the efficacy and feasibility of neoadjuvant concurrent chemoradiotherapy (cCRT) in selected grade 2–3 patients with limb or trunk wall STS, and to compare this schedule to a  sequential approach combining neoadjuvant chemotherapy and adjuvant radiotherapy.MethodsWe retrospectively included patients who underwent neoadjuvant cCRT at two comprehensive cancer centers from 1992 –2016. We then compared these results to those of patients treated with preoperative chemotherapy and postoperative radiotherapy from a third comprehensive cancer center with a pr...
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
ConclusionsOur study provides preclinical in vitro and in vivo evidence of the effectiveness of PEGylated liposomal doxorubicin as a  radiosensitizer, supporting its potential clinical development as a component of chemoradiotherapy.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
Pancreatic cancer (PC) is the fourth leading cause of cancer-related deaths in developed countries with an overall 5-year survival rate of 7% [1], and is expected to be the second cancer cause of death by 2030 [2]. Surgery still remains the best therapy for potentially curative purposes, but only 15-20% of the patients are candidates for resection. The resectability criteria are based on the absence of distant metastasis and the extent of vascular involvement. For a long time, tumours with no contact with major mesenteric or celiac vessels were considered resectable, and those with invasion of the arteries or mesenteric-po...
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Tags: Anti-Tumour Treatment Source Type: research
More News: Borderline Tumor | Cancer | Cancer & Oncology | Celiac Disease | Coeliac Disease | Pancreas | Pancreatic Cancer | Statistics | Study | Surgery